Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medicine Manufacturing		2.93B	2.69B	2.33B	1.63B	978.16M
Medicine Manufacturing Growth		8.85%	15.75%	42.92%	66.40%	5.85%
Total		2.93B	2.69B	2.33B	1.63B	978.16M
Total Growth		8.85%	15.75%	42.92%	66.40%	5.85%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North-East China		87.28M	124.19M	84.25M	64.47M	52.63M
North-East China Growth		-29.72%	47.40%	30.69%	22.50%	-0.12%
North China		282.25M	402.36M	458.60M	287.08M	148.23M
North China Growth		-29.85%	-12.26%	59.75%	93.67%	44.89%
East China		1.15B	903.60M	794.42M	589.81M	359.86M
East China Growth		26.77%	13.74%	34.69%	63.90%	12.49%
South China		339.99M	292.57M	244.32M	186.25M	127.62M
South China Growth		16.21%	19.75%	31.18%	45.95%	-22.03%
Central China		497.31M	418.56M	359.77M	249.27M	131.46M
Central China Growth		18.81%	16.34%	44.33%	89.62%	-11.78%
North-West China		158.38M	150.34M	106.95M	76.63M	37.82M
North-West China Growth		5.35%	40.57%	39.58%	102.61%	5.48%
South-West China		364.04M	351.82M	234.01M	146.86M	91.43M
South-West China Growth		3.47%	50.34%	59.34%	60.63%	26.84%
Export		54.75M	48.05M	-	-	-
Export Growth		13.94%	-	-	-	-
Unallocated		1.15M	1.02M	893.62K	818.09K	2.45M
Unallocated Growth		12.34%	14.17%	9.23%	-66.61%	-23.76%
Foreign		-	-	43.00M	26.47M	26.67M
Foreign Growth		-	-	62.42%	-0.74%	5.21%
Total		2.93B	2.69B	2.33B	1.63B	978.16M
Total Growth		8.85%	15.75%	42.92%	66.40%	5.85%

Source: S&P Global Market Intelligence.